Inhibrx Biosciences, Inc. · NASDAQ:INBX
Morgan Stanley reported a 7.90% stake in Inhibrx Biosciences, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 11, 2026
Morgan Stanley reported a 7.90% stake in Inhibrx Biosciences, Inc., 1,155,416 shares, as a passive investor on Dec 31, 2025. Filed Feb 11, 2026 (Schedule 13G).
- Stake
- 7.90%
- Shares
- 1,155,416
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 7.90% | 1,155,416 |
| Morgan Stanley Capital Services LLC | 6.30% | 918,011 |